In summary, PHD3 activity plays an important role in the response of cardiac tissue to injury and PHD3 may be a therapeutic target in myocardial infarction, diabetes-induced cardiac dysfunction and in cardiac injury caused by obstructive sleep apnoea. Here, EGLN3 is linked to diabetes mellitus.